Back to Trials
NCT07059806NARecruiting

T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes

Yale University

Start Date

9/5/2025

Completion Date

11/1/2027

Summary

Randomized controlled trial with a wait list control arm. Participants will be randomized 1:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Diabetes Centers. Patients assigned to T1CARE will receive support from a Community Health Navigator at Project Access-New Haven.

Detailed Description

Primary Objective To determine whether the T1CARE intervention improves resolution of health-related social needs compared to usual care. Secondary Objectives 1. To assess the feasibility and acceptability of the T1CARE intervention. 2. To evaluate the impact of T1CARE on patient-reported outcomes, including diabetes distress, illness intrusiveness, and quality of life. 3. To examine preliminary effects on clinical outcomes, particularly changes in HbA1c.

Eligibility Criteria

Age Range: 18 years to 40 years

Inclusion Criteria: * Type 1 Diabetes * fluent in Spanish or English who reside in the greater New Haven area Exclusion Criteria: * cognitive impairment and otherwise unable to give written informed consent about participating in this study

Interventions

BEHAVIORAL

T1CARE

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Type 1 Diabetes

Locations

Yale Adult Diabetes Center

New Haven, Connecticut 06520

United States

Yale Children's Diabetes Center

New Haven, Connecticut 06520

United States